Insmed Inc Stock Widgets and Gadgets
| INSM Stock | USD 25.02 0.08 0.32% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- INSM Insmed Inc
- Latest Soleno Therapeutics Provides Corporate Update and Reports Third ... - StreetInsider.com
- INSM 25.02 -0.08
- Low 24.78
- High 26.23
- Volume 1.3 M
- Alpha 0.26
- Beta 0.51
- Return On Equity -14.53
- Return On Asset -0.36
- Profit Margin (2.58) %
- Operating Margin (1.75) %
- Current Valuation 3.97 B
- Shares Outstanding 143.06 M
- Shares Owned By Insiders 1.29 %
- Shares Owned By Institutions 98.71 %
- Number Of Shares Shorted 14.17 M
- Price To Earning (8.70) X
- Price To Book 48.18 X
- Price To Sales 10.89 X
- Revenue 245.36 M
- Gross Profit 190.23 M
- EBITDA (458.21 M)
- Net Income (481.53 M)
- Cash And Equivalents 554.87 M
- Cash Per Share 4.62 X
- Total Debt 1.18 B
- Current Ratio 5.93 X
- Book Value Per Share (2.02) X
- Cash Flow From Operations (400.44 M)
- Short Ratio 10.72 X
- Earnings Per Share (5.29) X
- Target Price 41.42
- Number Of Employees 736
- Beta 1.4
- Market Capitalization 3.59 B
- Total Asset 1.66 B
- Retained Earnings (2.7 B)
- Working Capital 1.08 B
- Current Asset 28.15 M
- Current Liabilities 3.89 M
- Z Score -0.43
- Annual Yield 0.014 %
- Net Asset 1.66 B
- Accumulation Distribution 72638.31
- Daily Balance Of Power (0.06)
- Rate Of Daily Change 1.0
- Day Median Price 25.51
- Day Typical Price 25.34
- Price Action Indicator (0.53)
Market Snapshot Widget Example
DAX Index Germany | 16,215 0.30 | |
Taiwan Weighted Taiwan | 17,434 0.36 | |
PSI 20 Stock Portugal | 6,475 0.54 | |
CROBEX Croatia | 2,435 0.70 | |
Budapest SE Hungary | 57,878 0.93 | |
IDX 30 Jakarta Indonesia | 480.27 0.46 | |
ISEQ 20 Price Ireland | 1,418 0.33 | |
NYSE Comp USA | 16,089 0.79 | |
Tel Aviv 35 Israel | 1,774 1.71 | |
Coreshares Index Tracker South Afric | 980.00 1.45 | |
Mexico SPBMV IPC Mexico | 54,060 2.40 | |
KL Technology Malaysia | 62.50 0.4 | |
IBEX 35 Index Spain | 10,058 0.04 | |
SP Merval Argentina | 773,420 2.15 | |
Austrian Traded Index Austria | 3,291 0.35 | |
SPASX Dividend Opportunities Australia | 1,541 0.63 | |
HNX 30 Vietnam | 479.11 1.81 | |
Bucharest BET-NG Romania | 1,081 0.68 | |
AMS Small Cap Netherlands | 1,212 0.63 | |
Oslo Exchange Mutual Norway | 1,226 0.71 | |
BEL Small Belgium | 8,627 1.44 | |
RTSI Index Russia | 1,115 1.15 | |
Saudi Arabia Diversified Saudi Arabi | 6,494 1.21 | |
Basic Materials Brazil | 5,862 0.86 | |
TSX Industrials Capped Canada | 397.48 1.08 | |
Swiss Leader Price Switzerland | 1,717 0.40 | |
Athens General Comp Greece | 1,275 0.31 | |
Stock Exchange Of Thailand | 1,380 0.54 | |
PX Prague Stock Czech Repub | 1,384 0.37 | |
THE PHILIPPINE STOCK Philippines | 6,224 0.66 | |
WIG 30 Poland | 2,752 0.31 | |
BIST Electricity Turkey | 538.54 0.07 |
Investing Ideas
In addition to having Insmed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Insmed
Compare Insmed To Peers
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.29) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.167 | Return On Assets (0.36) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.